Bronchospasm

• FDA approval · 2017-08-07
  FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved Sun Pharmaceutical's original ANDA for ipratropium bromide and albuterol sulfate, a generic inhalation product for treating…

• CLINICAL_TRIALS trial_result · 2017-05-23
  Clinical Trial Update: Driving Pressure And EFL in Adult Cardiac Surgery

  Completed clinical trial evaluating driving pressure and EFL in adults undergoing cardiac surgery, with a focus on respiratory outcomes.

• CLINICAL_TRIALS trial_result · 2017-04-19
  Clinical Trial Update: Dose-Ranging Study of A006 DPI, in Adult Asthma Patients [Phase 2]

  Phase 2 dose-ranging study evaluating A006 DPI in adults with asthma has completed.

• CLINICAL_TRIALS trial_result · 2016-03-01
  Clinical Trial Update: Perioperative Change of Regional Ventilation During Spontaneous Breathing

  Clinical trial update reporting completion of a study on perioperative changes of regional ventilation during spontaneous breathing, sponsor…

• CLINICAL_TRIALS research · 2016-02-02
  Clinical Trial Update: Mechanical Ventilation During Cardiac Surgery [NA]

  Clinical trial update about mechanical ventilation during cardiac surgery. It notes related respiratory conditions such as respiratory failu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-10-21
  FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for terbutaline sulfate from Fresenius Kabi USA, LLC, indicating an additional authorization related…

• CLINICAL_TRIALS trial_result · 2014-03-11
  Clinical Trial Update: Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis [Phase 4]

  Phase 4 trial evaluating nebulised beclometasone for prevention of viral-induced wheeze; study status is completed.

• FDA approval · 2013-11-25
  FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals’ supplemental application for XOPENEX HFA (levalbuterol tartrate).

• CLINICAL_TRIALS trial_result · 2013-11-19
  Clinical Trial Update: Exercise-Induced Bronchospasm in Cystic Fibrosis

  This clinical trials update notes that a study examining exercise-induced bronchospasm in cystic fibrosis has completed.

• CLINICAL_TRIALS trial_result · 2013-07-15
  Clinical Trial Update: Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction [Phase 3]

  Phase 3 cross-over study evaluating albuterol HFA for exercise-induced bronchoconstriction was terminated.

• FDA approval · 2012-03-07
  FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a Teva supplemental application for Albuterol Sulfate HFA, indicating an approved change to the product’s NDA (e.g., labeling o…

• CLINICAL_TRIALS trial_result · 2011-12-08
  Clinical Trial Update: Observational Study on Obese Patients During General Anesthesia

  An observational study of obese patients undergoing general anesthesia. No results or conclusions are reported in this update.

• FDA approval · 2010-03-31
  FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)

  FDA approved a supplemental application for albuterol sulfate submitted by Nephron Pharmaceuticals Corporation.

• FDA approval · 2009-11-25
  FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  The FDA has approved a supplemental application for Epinephrine from Amneal Pharmaceuticals of New York LLC.

• FDA approval · 2009-09-08
  FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for albuterol sulfate by Sandoz Inc, updating an existing approved product.

• FDA approval · 2009-05-20
  FDA Approved: TERBUTALINE SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for terbutaline sulfate, establishing a generic version of this bronchodilat…

• FDA approval · 2007-03-29
  FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Chartwell RX, LLC.)

  The FDA approved a supplemental application for albuterol sulfate from Chartwell RX, LLC., updating an existing generic product.

• FDA approval · 2007-03-28
  FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)

  FDA approved a supplemental application for albuterol sulfate from Nephron Pharmaceuticals Corporation under an abbreviated new drug applica…